The Global Anti-Peptic Ulcer Drugs Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Anti-Peptic Ulcer Drugs industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anti-Peptic Ulcer Drugs market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Anti-Peptic Ulcer Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 188 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
I. INTRODUCTION 1
1.1 Report Scope and Methodology 1
1.2 Executive Summary 2
II. BUSINESS ENVIRONMENT 3
2.1 Economic Outlook 3
2.2 Key Economic Indicators 4
2.3 Industrial Output 4
2.4 Population and Labor 5
2.5 Foreign Investment 6
2.6 Foreign Trade 6
2.7 Financial and Tax Regulations 7
2.8 Banking System and Regulations 7
2.9 Foreign Exchange 8
2.10 Taxes, Tariff and Custom Duties 8
III. ANTI-PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS 12
3.1 Anti-Peptic Ulcer Drugs Industry Structure 12
3.2 Market Size 12
3.3Market Growth Drivers 17
3.4 Anti-Peptic Ulcer Drugs Sales Volume 18
3.5 Major Producer Facility Locations 18
3.6 Major Producers’ Sales Volume and Market Share 19
3.7 Labor Cost 21
3.8 Potential Entrants 21
3.9 Major Distributors 22
3.10 Major Foreign Investment 22
3.11 Technology Development 23
IV. ANTI-PEPTIC ULCER DRUGS PRODUCTION AND DEMAND 24
4.1 Market Overview by Drugs Classification 24
4.2 Proton Pump Inhibitor 32
4.3 H2 Receptor Antagonist 39
4.4 Gastric Mucosal Protective Drugs 46
4.5 Other Anti-Peptic Ulcer Drugs 53
4.6 Import and Export 60
4.7 Market Overview by Producers 70
4.8 Pricing Trend 71
V. ANTI-PEPTIC ULCER DRUGS MARKET OUTLOOK 72
5.1 Anti-Peptic Ulcer Drugs Markets Outlook Overview 72
5.2 Government Regulations 72
5.3 Health Care Insurance Industry Overview 73
5.4 Consumer Spending Trends 74
5.4.1 Northeast 74
5.4.2 North 75
5.4.3 Southeast 75
5.4.4 Central 76
5.4.5 Southwest 76
5.4.6 Northwest 77
5.5 Demographic Trends 77
5.6 Health Care Industry Trends 78
5.7 Hospitals and Hospital Beds 78
VI. MARKETING STRATEGIES 80
6.1 China Market Entry Overview 80
6.2 China’s Distribution System 81
6.3 Anti-Peptic Ulcer Drugs Distribution Channels 82
6.4 Transportation and Freight Infrastructure 83
6.5 Communications 85
6.6 China’s Market Entry 85
6.7 Export to China 85
6.7.1 Indirect Export 85
6.7.2 Direct Export 86
6.8 License and Contract Manufacture 86
6.9 Assembling in China 88
6.10 Contract Manufacturing 88
6.11 Trade Permit 90
6.12 Investment 90
6.13 Equity Joint Venture 91
6.14 Contractual Joint Venture 92
6.15 Wholly Foreign-Owned Enterprise 93
VII. ANTI-PEPTIC ULCER DRUGS PRODUCER DIRECTORY 94
7.1 AstraZeneca 94
7.2 Ask-pharm 94
7.3 Takeda 95
7.4 Yangtze River Pharm (YRPG) 95
7.5 Shandong Luoxin 96
7.6 Huadong Medicine 96
7.7 Changzhou Siyao 96
7.8 Beijing Yuekang 96
7.9 Guangdong Dahua 96
7.10 Xian Janssen 96
List of Tables and Figures
Figure China GDP (Billion RMB) And Growth Rate 3
Figure GDP Growth Rates 3
Table China Key Economic Indicators 2010-2014 4
Table China Industrial Output 2010-2014 4
Table China Population 2010-2014 5
Table China Age Composition and Dependency Ratio of Population 5
Table China Foreign Investment (Hundred Million US Dollars) 2010-2014 6
Table China Total Value of Imports and Exports 6
Figure 2010-2015 Total Anti-Peptic Ulcer Drugs Sales Volume (M USD) 12
Table 2015 Anti-Peptic Ulcer Drugs Sales Volume (M USD) and Market Share by Drugs Classification 12
Figure 2015 Anti-Peptic Ulcer Drugs Sales Volume by Drugs Classification 13
Table 2015 Proton Pump Inhibitors Sales Volume (M USD) and Market Share by Drugs Classification 13
Figure 2015 Proton Pump Inhibitors Market Share by Drugs Classification 14
Table 2015 H2 Receptor Antagonist Sales Volume (M USD) and Market Share by Drugs Classification 14
Figure 2015 H2 Receptor Antagonist Market Share by Drugs Classification 15
Table 2015 Gastric Mucosal Protective Drugs Sales Volume (M USD) and Market Share by Drugs Classification 15
Figure 2015 Gastric Mucosal Protective Drugs Market Share by Drugs Classification 16
Table 2015 Other Anti-Peptic Ulcer Drugs Sales Volume (M USD) and Market Share by Drugs Classification 16
Figure 2015 Other Anti-Peptic Ulcer Drugs Market Share by Drugs Classification 17
Table 2010-2015 Anti-Peptic Ulcer Drugs Sales Volume (M USD) and Growth Rate 18
Figure 2010-2015 Anti-Peptic Ulcer Drugs Sales Volume and Growth Rate 18
Table Major Producer Facility Locations 18
Table 2010-2015 Major Anti-Peptic Ulcer Drugs Producer Sales Volume (M USD) 19
Table 2010-2015 Major Anti-Peptic Ulcer Drugs Producer Sales Market Share 20
Table 2014 Global Average Wage (USD/ Month) by Country 21
Figure FDI Inflows By Countries 22
Figure FDI Inflows By Industry 22
Table 2010-2015 Anti-Peptic Ulcer Drugs Sales Volume (M USD) by Drugs Classification 24
Table 2010-2015 Anti-Peptic Ulcer Drugs Market Share by Drugs Classification 24
Figure 2010-2015 Total Anti-Peptic Ulcer Drugs Sales Volume (M USD) 24
Figure 2010-2015 Total Anti-Peptic Ulcer Drugs Import (M USD) 25
Figure 2010-2015 Total Anti-Peptic Ulcer Drugs Export (M USD) 25
Figure 2010-2015 Anti-Peptic Ulcer Drugs Sales Volume (M USD) by Drugs Classification 26
Figure 2010 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 27
Figure 2011 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 28
Figure 2012 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 29
Figure 2013 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 30
Figure 2014 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 31
Figure 2015 Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 32
Table 2010-2015 Proton Pump Inhibitors Sales Volume (M USD) by Drugs Classification 32
Table 2010-2015 Proton Pump Inhibitors Market Share by Drugs Classification 32
Figure Proton Pump Inhibitors Sales Volume and Market Share 33
Figure 2010 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 34
Figure 2011 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 35
Figure 2012 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 36
Figure 2013 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 37
Figure 2014 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 38
Figure 2015 Proton Pump Inhibitor Sales Volume Market Share by Drugs Classification 39
Table 2010-2015 H2 Receptor Antagonist Sales Volume (M USD) by Drugs Classification 39
Table 2010-2015 H2 Receptor Antagonist Market Share by Drugs Classification 39
Figure H2 Receptor Antagonist Sales Volume and Market Share 40
Figure 2010 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 41
Figure 2011 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 42
Figure 2012 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 43
Figure 2013 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 44
Figure 2014 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 45
Figure 2015 H2 Receptor Antagonist Sales Volume Market Share by Drugs Classification 46
Table 2010-2015 Gastric Mucosal Protective Drugs Sales Volume (M USD) by Drugs Classification 46
Table 2010-2015 Gastric Mucosal Protective Drugs Market Share by Drugs Classification 47
Figure Gastric Mucosal Protective Drugs Sales Volume and Market Share 47
Figure 2010 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 48
Figure 2011 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 49
Figure 2012 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 50
Figure 2013 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 51
Figure 2014 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 52
Figure 2015 Gastric Mucosal Protective Drugs Sales Volume Market Share by Drugs Classification 53
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Sales Volume (M USD) by Drugs Classification 53
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Market Share by Drugs Classification 53
Figure Other Anti-Peptic Ulcer Drugs Sales Volume and Market Share 54
Figure 2010 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 55
Figure 2011 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 56
Figure 2012 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 57
Figure 2013 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 58
Figure 2014 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 59
Figure 2015 Other Anti-Peptic Ulcer Drugs Sales Volume Market Share by Drugs Classification 60
Table 2010-2015 Anti-Peptic Ulcer Drugs Import (M USD) by Drugs Classification 60
Table 2010-2015 Anti-Peptic Ulcer Drugs Import Market Share by Drugs Classification 60
Figure 2010-2015 Anti-Peptic Ulcer Drugs Import (M USD) by Drugs Classification 61
Table 2010-2015 Proton Pump Inhibitors Import (M USD) by Drugs Classification 61
Table 2010-2015 Proton Pump Inhibitors Import Market Share by Drugs Classification 61
Figure 2010-2015 Proton Pump Inhibitors Import (M USD) by Drugs Classification 62
Table 2010-2015 H2 Receptor Antagonist Import (M USD) by Drugs Classification 62
Table 2010-2015 H2 Receptor Antagonist Import Market Share by Drugs Classification 62
Figure 2010-2015 H2 Receptor Antagonist Import (M USD) by Drugs Classification 63
Table 2010-2015 Gastric Mucosal Protective Drugs Import (M USD) by Drugs Classification 63
Table 2010-2015 Gastric Mucosal Protective Drugs Import Market Share by Drugs Classification 63
Figure 2010-2015 Gastric Mucosal Protective Drugs Import (M USD) by Drugs Classification 64
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Import (M USD) by Drugs Classification 64
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Import Market Share by Drugs Classification 64
Figure 2010-2015 Other Anti-Peptic Ulcer Drugs Import (M USD) by Drugs Classification 65
Table 2010-2015 Anti-Peptic Ulcer Drugs Export (M USD) by Drugs Classification 65
Table 2010-2015 Anti-Peptic Ulcer Drugs Export Market Share by Drugs Classification 65
Table 2010-2015 Proton Pump Inhibitors Export (M USD) by Drugs Classification 66
Table 2010-2015 Proton Pump Inhibitors Export Market Share by Drugs Classification 66
Figure 2010-2015 Proton Pump Inhibitors Export (M USD) by Drugs Classification 67
Table 2010-2015 H2 Receptor Antagonist Export (M USD) by Drugs Classification 67
Table 2010-2015 H2 Receptor Antagonist Export Market Share by Drugs Classification 67
Figure 2010-2015 H2 Receptor Antagonist Export (M USD) by Drugs Classification 68
Table 2010-2015 Gastric Mucosal Protective Drugs Export (M USD) by Drugs Classification 68
Table 2010-2015 Gastric Mucosal Protective Drugs Export Market Share by Drugs Classification 68
Figure 2010-2015 Gastric Mucosal Protective Drugs Export (M USD) by Drugs Classification 69
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Export (M USD) by Drugs Classification 69
Table 2010-2015 Other Anti-Peptic Ulcer Drugs Export Market Share by Drugs Classification 69
Figure 2010-2015 Other Anti-Peptic Ulcer Drugs Export (M USD) by Drugs Classification 70
Table 2010-2015 Major Anti-Peptic Ulcer Drugs Producer Sales Volume 70
Table 2010-2015 Major Anti-Peptic Ulcer Drugs Producer Sales Market Share 70
Figure 2012-2020 Anti-Peptic Ulcer Drugs Markets Outlook 72
Figure China Healthcare Ecosystem 73
Table Health Care Industry Overview 2011-2015 73
Figure the Structure of Per Capita Expenditure in the Northeast of China in 2014 74
Figure the Structure of Per Capita Expenditure in the North of China in 2014 75
Figure the Structure of Per Capita Expenditure in the Southeast of China in 2014 75
Figure the Structure of Per Capita Expenditure in the Central of China in 2014 76
Figure the Structure of Per Capita Expenditure in the Southwest of China in 2014 76
Figure the Structure of Per Capita Expenditure in the Northwest of China in 2014 77
Figure China Demographic Trends 77
Figure China Health Care Industry Trends 78
Figure China Hospitals 2010-2015 78
Figure China Hospital Beds 2010-2015 79
Table China prescription drug sales channels 81
Figure Freight traffic by province in China 2014 (Million Tonne) 83
Figure Railway map of China 84
Figure Revenue of the telecommunications industry in China from June 2014 to June 2015 (in billion yuan) 85
Table China encouraged category Comparison 93
Table Takeda Company profile 95
